Cargando…
Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells
PURPOSE: Chemotherapy drugs used to treat lung cancer are associated with drug resistance and severe side effects. There have been rising demands for new therapeutic candidates and novel approaches, including combination therapy. Here, we aimed to investigate the combinatorial effect of a dendrosoma...
Autores principales: | Eslami, Seyed Sadegh, Jafari, Davod, Ghotaslou, Abbas, Amoupour, Moein, Asri Kojabad, Amir, Jafari, Rasool, Mousazadeh, Navid, Tarighi, Parastoo, Sadeghizadeh, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460814/ https://www.ncbi.nlm.nih.gov/pubmed/37646049 http://dx.doi.org/10.34172/apb.2023.050 |
Ejemplares similares
-
Dendrosomal nanocurcumin and p53 overexpression synergistically trigger apoptosis in glioblastoma cells
por: Keshavarz, Reihaneh, et al.
Publicado: (2016) -
Up-regulation of miR-21 decreases chemotherapeutic effect of dendrosomal curcumin in breast cancer cells
por: Esmatabadi, Mohammad Javad Dehghan, et al.
Publicado: (2017) -
Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC)
por: Sardarabadi, Parvaneh, et al.
Publicado: (2021) -
Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells
por: Tahmasebi Mirgani, Maryam, et al.
Publicado: (2014) -
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment
por: Tarighi, Parastoo, et al.
Publicado: (2021)